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AbstrACt
Objectives The aims of this study were to: (1) describe 
alcohol industry corporate social responsibility (CSR) 
actions conducted across six global geographic regions; 
(2) identify the benefits accruing to the industry (‘doing 
well’); and (3) estimate the public health impact of the 
actions (‘doing good’).
setting Actions from six global geographic regions.
Participants A web-based compendium of 3551 industry 
actions, representing the efforts of the alcohol industry 
to reduce harmful alcohol use, was issued in 2012. The 
compendium consisted of short descriptions of each 
action, plus other information about the sponsorship, 
content and evaluation of the activities. Public health 
professionals (n=19) rated a sample (n=1046) of the 
actions using a reliable content rating procedure.
Outcome measures WHO Global strategy target area, 
estimated population reach, risk of harm, advertising 
potential, policy impact potential and other aspects of the 
activity.
results The industry actions were conducted 
disproportionately in regions with high-income countries 
(Europe and North America), with lower proportions in 
Latin America, Africa and Asia. Only 27% conformed 
to recommended WHO target areas for global action to 
reduce the harmful use of alcohol. The overwhelming 
majority (96.8%) of industry actions lacked scientific 
support (p<0.01) and 11.0% had the potential for doing 
harm. The benefits accruing to the industry (‘doing well’) 
included brand marketing and the use of CSR to manage 
risk and achieve strategic goals.
Conclusion Alcohol industry CSR activities are unlikely 
to reduce harmful alcohol use but they do provide 
commercial strategic advantage while at the same time 
appearing to have a public health purpose.
IntrOduCtIOn 
Corporate social responsibility (CSR) refers 
to business practices that help companies 
manage their economic, social and environ-
mental impacts, and their relationships in 
key areas of influence, such as the market-
place, the supply chain, the community and 
the public policy arena.1 2 The notion that 
commercial enterprises can ‘do well’ (eg, 
improve their brand image, increase their 
profitability) by ‘doing good’ (ie, contribute 
to socially beneficial groups and causes) 
has motivated this rapidly expanding global 
movement.3 4 While the motives behind CSR 
vary, they appear to be indirectly related 
to the financial performance of corpora-
tions.5 6 CSR has been described as one of 
the few remaining strategies for unhealthy 
commodity industries (eg, tobacco, alcohol, 
gambling) to present their products in a posi-
tive light and thereby improve their reputa-
tions.7 8 Evidence indicates that the tobacco 
industry used CSR activities to improve their 
image, deflect criticism, enable access to 
policy makers and mitigate legal risks, thereby 
increasing profits.7 9–11 Despite a substan-
tial amount of published research that has 
questioned the motives of the alcohol indus-
try’s CSR activities,12–15 little is known about 
the characteristics of these activities or their 
impact on public health.16 
strengths and limitations of this study
 ► Use of a global database of industry activities that 
is likely to be comprehensive and representative of 
the alcohol industry’s corporate social responsibility 
activities.
 ► A 30% sample was selected from the International 
Alliance for Responsible Drinking database. Different 
conclusions may have resulted with a larger sample.
 ► Unable to determine whether the industry actions 
represented significant charitable contributions or 
were merely activities that in some cases would 
have been conducted anyway (eg, those required 
by law).
 ► Although all raters were initially trained to an ac-
ceptable level of reliability, we cannot rule out dif-
ferential bias in the raters recruited from different 
regions.
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The alcohol industry has invested significant resources 
to promote CSR initiatives around the world. In what is 
perhaps the largest initiative of its kind, on 9 October 
2012, 11 major global producers of alcoholic bever-
ages and two major trade associations issued a set of 
‘Producers’ Commitments’ to reduce harmful drinking 
(http://www. producerscommitments. org/ default. aspx). 
To illustrate the industry’s efforts to fulfil these commit-
ments, an industry-sponsored database (initially posted at 
initiatives. global- actions. org, but subsequently removed) 
was created by the International Centre for Alcohol Poli-
cies (ICAP), now called the International Alliance for 
Responsible Drinking (IARD). The database was an inven-
tory of over 3500 industry actions conducted in support 
of the WHO Global strategy to reduce the harmful use 
of alcohol (Global strategy).17 The Global strategy is a 
menu of 10 evidence-based policy options that the WHO 
member states can use to achieve reductions in harmful 
alcohol use. Contributors to the industry-supported data-
base included multinational producers of beer, wine and 
distilled spirits; alcohol distributors and wholesalers; 
members of related industries, such as hotels, restaurants, 
bars and advertisers; and industry-affiliated social aspect 
and public relations organisations (SAPROs).
The present study had three aims: (1) to describe the 
global distribution of the industry actions according to 
geographic regions and high-resource and low-resource 
areas; (2) to estimate the benefits accruing to the industry 
in terms of marketing potential, impact on regulatory 
policy and type of CSR strategy; and (3) to evaluate the 
public health impact of the industry actions in terms of 
their likely effectiveness and potential harm. We were 
particularly interested in the extent to which the indus-
try’s actions conformed to options recommended by 
WHO and the evidence base that informed the Global 
strategy. This is the first comprehensive analysis of the 
3500 industry actions posted on the ICAP/IARD website. 
Analyses of the drinking and driving initiatives18 and the 
marketing potential of the initiatives conducted in Latin 
America and the Caribbean15 have been published in 
prior reports.
Considering the significant contribution alcohol makes 
to global disease burden,17 this study evaluated whether 
the Global Producers’ actions reflect evidence-based 
approaches likely to reduce alcohol harm, or whether 
they are mainly conducted as a form of ‘stakeholder 
marketing’19 designed to produce favourable public 
perceptions and less restrictive regulatory environments. 
To answer this question, we conducted a systematic evalu-
ation of a sample of the industry actions using a content 
rating procedure designed to evaluate their public health 
implications and commercial benefits.
MethOds
From 2014 until 2016, 19 trained raters from Brazil, Argen-
tina, the USA, the European Union (EU) and Australia 
analysed a sample of 1046 industry actions. Data were 
exported from the website’s print view from August 2013 
to August 2015 prior to the database being shut down 
without explanation in April 2016. Actions were sorted by 
region according to the geoscheme created by the United 
Nations Statistics Division (UNSD), and then alpha-
betically by action title. Units were selected so that the 
sampling strata maintained the proportions of the ‘target 
population,’ which in this case is the total number of 
industry actions (n=3551). This means that each stratum 
(UNSD geographic region) has the same sampling frac-
tion. Using data from two countries (USA and UK) and 
one region (Latin America and the Caribbean) where all 
industry actions were rated, we determined that a propor-
tionate sample size of 30% provided an accurate estimate 
of the actual distribution. The random sample generator 
function in SPSS Windows V.24 was used to select the 30% 
sample from each United Nations (UN) region and those 
labelled by ICAP/IARD as ‘international’ or ‘global’ 
(n=1046).
descriptive measures
An evidence benchmarking protocol was used to extract 
information on the sponsoring organisation, partners, 
year started, country and industry-reported evaluation 
(if applicable) for each industry action sampled from the 
database. Based on the short qualitative summaries of the 
actions (mean words per action=132) provided on the 
website, we assigned numeric codes for the type of part-
ners listed (eg, government, non-governmental organisa-
tion, SAPRO, trade association, etc.) and for the type of 
evaluation reported by the industry (process evaluation, 
uncontrolled outcome evaluation, controlled outcome 
evaluation or ‘does not meet the minimum criteria’). 
We used country names to define geographic regions 
following the UNSD classification of geographic regions 
(eg, Africa, Asia) and subregions (eg, Latin America and 
the Caribbean) (https:// unstats. un. org/ unsd/ method-
ology/ m49/) and the World Bank database (https:// data. 
worldbank. org/ country) to define country income-level.
Estimated population reach refers to the number of 
people in the target group that could be served when 
an intervention is provided under real-world conditions. 
Coding options were none, small, moderate and large. 
This variable is relative and was coded after raters were 
trained using model scenarios. For example, if the action 
was implemented across the entire USA, but only reached 
10 000 people, it was coded as small.
In addition to these descriptive characteristics of the 
industry actions, we also coded whether the activity was 
likely to produce benefits to the alcohol industry, and 
the ways in which society in general would benefit (or be 
harmed). These variables and their operational defini-
tions are described in table 1.
Measures of industry benefits (‘doing well’)
Each industry action was coded for marketing potential. 
If the action involved giving away promotional materials 
or marketed a specific product, it was coded as having 
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‘possible’ marketing potential. Actions that did not meet 
this criterion and all activities undertaken by trade organ-
isations or SAPROs were rated as having no marketing 
potential.
The policy impact potential of each action (ie, whether 
the action had the potential to impact national or local 
policy) was coded as ‘none’ or ‘possible’. We coded only 
activities that had a clear political or policy impact as 
‘possible’.
The type of CSR was coded based on previously 
published definitions.20 Coding options were ‘none’—not 
having a social or environmental responsibility interpre-
tation or not reflecting positively on the company; ‘altru-
istic’—responsibilities that reflect giving back time or 
money to contribute solely to the well-being of a commu-
nity or society at the possible expense of the business; 
‘risk management’—legal or ethical obligations that are 
socially required; or ‘strategic’—aimed at achieving busi-
ness goals while also promoting societal welfare. Coders 
were provided with examples and indicators for each type 
of CSR to minimise subjective bias.
societal benefit measures (‘doing good’)
Raters assessed whether the initiative fit into any of the 
10 WHO Global strategy target areas. If a clear match was 
not possible, based on descriptions in the WHO17 Global 
strategy, the initiative was coded as either ‘not classifiable’ 
because of insufficient information, or ‘not compatible 
with any of the ten categories.’
Activity type was coded for each action in order to iden-
tify actions that had evidence of effectiveness.21 Activi-
ties were coded according to a list of 67 interventions, 
campaigns, programmes and policies that had been eval-
uated in prior research for effectiveness.21 Actions that 
did not fit these activity types were coded as ‘other’, which 
had 12 subcodes. These included administrative changes 
by a particular company, online media campaigns, indus-
try-sponsored research, conference sponsorships, infor-
mation for parents, promotional events and activities 
unrelated to reducing the harmful use of alcohol, such as 
scholarships for students being trained in the hospitality 
industry.
Table 1 Measurement domains, variables measured and coding options used in content analysis of alcohol industry 
corporate social responsibility activities
Measurement domain Variable name What is measured Coding options
Industry benefit measures 
(‘Doing well’)
Marketing/advertising 
potential
Whether the action has the 
potential to promote a specific 
brand or product.
None; possible
Policy impact potential Whether the action has the 
potential to impact national or local 
policy
None; possible
CSR type Likely operational impact rather 
than presumed motivation of 
industry actor
None, strategic, risk management, 
altruistic
Societal benefit measures 
(‘Doing good’)
WHO Global strategy 
target area
Whether the action covers one of 
the 10 target areas recommended 
by the WHO Global strategy
0=Not consistent with any Global 
strategy area
1–10=consistent with one of the 10 
Global strategy areas
11=too vague to classify
Activity type Whether the action fit a list of 67 
interventions, programmes and 
policies that have been evaluated in 
prior research for effectiveness
Choice of 79 activity types, of 
which 67 have been evaluated and 
12 ‘other’ types which had not 
been subjected to research
Evidence of 
effectiveness
Estimate its potential for reducing 
alcohol-related harm based on the 
scientific literature
Activity types were coded as 
follows:
0=evidence indicates a lack of 
effectiveness
1=evidence for limited effectiveness
2=evidence for moderate 
effectiveness
3=evidence of a high degree of 
effectiveness
9=no studies have been undertaken 
or there is insufficient evidence on 
which to make a judgement
Risk of harm potential Whether the action had the 
potential to cause harm or damage 
based on available evidence
None; possible
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Evidence of effectiveness was coded from the public 
health perspective21 22 by assigning scores to each coded 
activity to estimate its potential for reducing alcohol-re-
lated harm: 0=lack of effectiveness; 1=limited effec-
tiveness; 2=moderate effectiveness; 3=high degree of 
effectiveness; 9=no studies have been undertaken or there 
is insufficient evidence on which to make a judgement.
Harm potential was also assessed for each action. If an 
action was considered likely to pose a risk of harm based 
on current theory or evidence, harm potential was coded 
as ‘possible’. Raters were instructed to code harm poten-
tial very conservatively, based on the available evidence.
Training of raters
Nineteen public health professionals with expertise in 
alcohol control policy from Latin America (9), USA (3), 
the EU (5) and Australia (2) analysed the industry actions 
within their respective regions. A rater training workshop 
was conducted by the protocol authors with each regional 
team prior to the start of the global project to ensure 
consistency. After the raters were trained at regional 
sites using a standardised protocol, they each rated the 
same 35 randomly selected actions from the database, 
compared their ratings to the ratings of the protocol 
authors and discussed discrepancies with experts until 
consensus was achieved. A second round of another 35 
randomly selected initiatives was then conducted. After 
achieving an acceptable level of inter-rater reliability 
(kappa >0.60), the raters continued rating the remaining 
actions independently.
Statistical analyses
Data was analysed using SPSS for Windows V.24 
(Armonk, New York, USA: IBM Corp.). Omnibus χ2 tests 
were used to determine significant differences in vari-
ables that were dichotomous (eg, marketing potential) 
or categorical (eg, sponsoring organisations) across UN 
geographic regions that conformed approximately to 
the WHO regions used for administrative and statistical 
purposes.
Significance was set at p<0.05. To understand the 
meaning of a significant omnibus test, several logistic 
regressions were used. In each model, a single UN 
region was compared against the rest of the world for 
a specific dependent variable. For instance, the prev-
alence of industry actions that had marketing poten-
tial in Africa was compared against the prevalence of 
industry actions with marketing potential in all other 
UN regions combined. Statistical significance was deter-
mined using 95% CIs of the resultant ORs. This method 
allowed for increased interpretability of the results, 
while limiting the impact of type I error, which would 
have been a serious concern had pairwise comparisons 
been implemented. χ2 tests and Spearman correla-
tions were also used to determine whether population 
reach was correlated with marketing potential and 
effectiveness.
results
Table 2 presents descriptive information about the 
actions. More than half of the actions were conducted 
in Europe (57.7%), and 76% were based in high-income 
countries (HICs). Less than 8% of actions were conducted 
in lower-middle and low-income countries. Despite the 
claims of ICAP/IARD that the actions were conducted 
‘in support of’ the Global strategy,17 most (65.7%) were 
initiated prior to the 2010 release of the Global strategy, 
and some (10.4%) prior to 2000, according to the dates 
provided in the listings.
doing well: benefits accruing to the industry
The first three sections of table 3 show the regional 
percentages, ORs and CIs of three benefits accruing to 
the alcohol industry. Overall, 26.5% of the actions were 
rated as having a marketing potential, 15.2% had the 
potential to have a policy impact and 18.0% were classi-
fied as having a ‘strategic’ CSR function. The proportion 
of actions that were considered to have one or more of 
these benefits was 46.0%.
Activities coded as having a marketing potential 
included giving away branded merchandise and adding a 
responsible drinking message to the product’s commercial 
advertising materials. There were significant differences 
in industry actions that contained marketing potential 
across UN regions (χ2 = 47.44; df=6; p<0.01). Actions 
conducted in Latin America and Africa were significantly 
more likely to have marketing potential compared with 
actions conducted in all other regions (table 3). Actions 
conducted in Oceania had a significantly lower likelihood 
of marketing potential.
We also evaluated the association between estimated 
population reach and marketing potential. Of the 277 
actions with marketing potential, 44.4% had moderate 
to large population reach (χ2 = 29.31; df=1; p<0.01). 
The Spearman correlation indicated a positive associa-
tion, which was statistically significant (rs(1046)=0.158, p 
=<0.01).
Fifteen per cent (15.2%) of actions were found to have 
the potential to influence policies, for example, spon-
soring of a traffic safety council or conducting workshops 
for policy makers (table 3). Actions with policy potential 
differed significantly among regions (χ2 = 26.58; df=6; 
p<0.01). Actions in Africa, Oceania and those conducted 
on an international scale were considered more likely to 
have a policy impact.
Regarding the type of CSR, the majority of sampled 
actions (77.4%) were coded as ‘risk management’ 
(eg, ‘responsible drinking message added to labels’) 
while 18.0% were coded as strategic CSR (eg, a confer-
ence promoting self-regulation of alcohol advertising) 
(table 3). The number of actions categorised as having 
a strategic CSR approach was significantly different 
across regions (χ2 = 36.15; df=6; p<0.01). A strategic 
CSR approach was more likely to be used on an interna-
tional scale and in the African Region. Actions in North 
America were less likely to take a strategic CSR approach. 
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Less than 2% (1.6%) of actions were coded as altruistic 
type CSR. Three per cent of actions were coded as not 
fitting any CSR approach.
doing good: public health impact of the industry actions
Table 4 shows the regional percentages, ORs and CIs 
of industry actions that were consistent with the WHO 
Global strategy targets. Overall, only 27.1% were consid-
ered classifiable into the WHO target areas, which was 
significantly different between UN regions (χ2 = 34.68; 
df=6; p<0.01). Actions in Africa and North America were 
more likely to fall under one of the 10 Global strategy 
target areas, although the majority of actions remained 
inconsistent with the Global strategy.
Figure 1 compares the proportions classified into 
the 10 WHO Global strategy areas by the public health 
raters with those classified by the industry and reported 
on the ICAP/IARD website. The table shows substantial 
discrepancies between the proportions assigned to three 
key areas: leadership (22.3% ICAP/IARD vs 3.0% public 
health raters), drinking and driving initiatives (28.7% vs 
14.1%) and reducing negative consequences (27.4% vs 
3.6%). The main reason for these discrepancies was that 
the public health raters, using WHO definitions of the 
target areas, were not able to classify 72.9% of the actions 
into any of the 10 categories, either because they clearly 
did not fit the definitions (39.3%) or they were too vague 
(33.6%).
In addition to the ratings based on the WHO 
target areas, separate ratings were conducted to classify 
the specific type of activity and to estimate its potential 
effectiveness. Table 5 shows how the actions were classi-
fied according to activity type and evidence for effective-
ness. The majority of actions (75.9%) were coded ‘other’ 
activity types which have not been evaluated in the liter-
ature. Activities coded here include posters, leaflets and 
websites, industry-sponsored conferences, funding of 
SAPRPOs and updates to producer employee handbooks. 
Each activity code was assigned an effectiveness score 
based on expert consensus ratings.21 22 Since there were 
only 33 actions coded as limited, moderate or high effec-
tiveness, these three categories were collapsed. There 
were considerably more ineffective actions or actions of 
unknown effectiveness (96.8%) compared with effec-
tive actions overall (p<0.01). Nearly half of the actions 
(46.8%) were activities that have not been evaluated in 
the research. Over 20% (21.0%) were activities that were 
not relevant to public health (ie, funding of SAPROs). 
Twenty-nine per cent of the actions have been evaluated 
in the alcohol literature21 and have been found not to 
be effective; 1.3% were found to have limited effective-
ness. Only 1.8% of total activities sampled had evidence 
of moderate to high effectiveness (eg, minimum legal 
alcohol purchase age).
Another part of the content ratings focused on 
the potential of the action to cause harm (eg, using 
the Grand Prix racing event to launch an awareness 
campaign). Eleven per cent of actions were found to have 
Table 2 Characteristics of industry actions to reduce 
harmful drinking online compendium (n=1046)
n (%)
Region*
  Africa 69 (6.6)
  Asia 63 (6.0)
  Europe 604 (57.7)
  Latin America 67 (6.4)
  North America 163 (15.6)
  Oceania 40 (3.8)
  International 40 (3.8)
Country income level†
  High 797 (76.2)
  Upper-middle 127 (12.1)
  Lower-middle 59 (5.6)
  Low 22 (2.1)
  Multiple 41 (3.9)
Year started‡
  1990–1999 105 (10.4) 
  2000–2009 559 (55.3) 
  2010–2014 346 (34.2)
Estimated population reach 
  None 218 (20.8) 
  Small 499 (47.7) 
  Moderate 218 (20.8) 
  Large 111 (10.6) 
Sponsor
  Producer 537 (51.3)
  SAPRO 306 (29.3)
  Trade association 182 (17.4)
  Other 21 (2.0)
Partner 
  None reported 509 (48.7)
  Governmental 64 (6.1)
  NGO/University 92 (8.8)
  SAPRO/Trade association 55 (5.3)
  Commercial 65 (6.2)
  Multiple partner types 170 (16.3)
  ‘Non specified collaborator’/Other 91 (8.7)
Industry-reported evaluation 
  None reported 688 (65.7)
  Does not meet minimum criteria 92 (8.8)
  Process 217 (20.7)
  Outcome 49 (4.7)
*Regions according to United Nations Statistics Division 
classifications.
†According to World Bank classifications.
‡n=1010 because of missing data.
NGO, non-governmental organisation; SAPRO, social aspect and 
public relations organisation.
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the potential to cause harm from a public health perspec-
tive, which was significantly different across regions (χ2 
= 32.98; df=6; p<0.01). Actions that had a potential for 
harm were most likely to occur in Latin America and the 
Caribbean (LAC) and Oceania and were least likely to 
occur in North America (table 4).
dIsCussIOn
The present analysis of CSR activities conducted by alcohol 
industry bodies ostensibly in support of the WHO’s Global 
strategy adopted a perspective that contrasted public health 
interests with the commercial interests of the alcohol 
industry. While the actions were found to be conducted 
disproportionately in HICs of Europe and North America, 
actions in Africa and LAC were found to be significantly asso-
ciated with an increased likelihood for marketing potential. 
This is consistent with research suggesting that competitive 
industries that depend on marketing to sell their products 
are more likely to include product marketing in their CSR 
activities,3 and that the large producers are targeting devel-
oping countries.23 24 The positive association found between 
marketing potential and population reach provides further 
indication that industry segments may be using the industry 
actions for marketing purposes.
Regarding the benefits accruing to the alcohol industry 
(‘doing well’), our analyses show that the industry’s CSR 
activities tend overwhelmingly to be oriented towards 
risk management and achieving strategic goals. Research 
suggests that industry-funded educational campaigns lead 
to positive views of that industry.25 As Bond, Daube and 
Chikritzhs26 note, alcohol industry documents further 
demonstrate the public relations benefit of ‘responsibility’ 
messages and education campaigns.
Although alcohol industry bodies promoted the online 
inventory as a reflection of their commitments to the WHO 
2010 Global strategy, 72.9% of the industry actions we eval-
uated were scored as not conforming to the WHO recom-
mended target categories. Some activities (eg, a brewery’s 
60th anniversary celebration) seemed to contradict the 
intent of the Global strategy and were seemingly inconsis-
tent with the stated purpose of the alcohol industry actions. 
There were also major differences between the industry’s 
Table 3 Percentages, ORs and 95% CIs by region for marketing potential, potential policy impact and strategic corporate 
social responsibility (CSR)
Region*
Marketing potential Policy impact Strategic CSR actions
% OR† 95% CI % OR† 95% CI % OR† 95% CI
Africa (n=69) 43.5 3.08 1.24 to 7.64 29.0 2.46 1.41 to 4.26 33.3 2.45 1.45 to 4.16
Asia (n=63) 15.9 0.50 0.25 to 1.00 6.9 1.19 0.60 to 2.34 20.6 1.77 0.87 to 3.61
Europe (n=604) 24.0 0.74 0.56 to 0.97 13.9 0.79 0.56 to 1.10 15.2 0.64 0.47 to 0.89
LAC (n=69) 53.7 4.65 1.87 to 11.56 7.5 0.43 0.17 to 1.09 22.4 1.34 0.73 to 2.44
North America (n=163) 27.0 1.03 0.70 to 1.50 10.4 0.6 0.35 to 1.03 11.0 0.52 0.31 to 0.87
Oceania (n=40) 10.0 0.29 0.10 to 0.84 27.5 2.19 1.07 to 4.98 27.5 1.77 0.87 to 3.61
International (n=40) 33.3 0.68 0.31 to 1.50 27.5 2.19 1.07 to 4.98 40.0 3.22 1.67 to 6.19
Totals (n=1046) 26.5 – – 15.2 – – 18.0 – – 
*Regions based on United Nations Statistics Division classifications.
†United Nations region compared with the rest of the world.
LAC, Latin America and Caribbean.
Table 4 Percentage, ORs and 95% CIs of actions rated as meeting WHO Global strategy target areas and actions with 
potential for harm, by region (n=1046)
Region*
WHO Global strategy target area met Potential for harm
% OR† 95% CI % OR† 95% CI
Africa (n=69) 39.1 1.81 1.09 to 2.99 7.2 0.61 0.24 to 1.56
Asia (n=63) 23.8 0.83 0.45 to 1.51 15.9 1.57 0.77 to 3.19
Europe (n=604) 24.8 0.76 0.58 to 1.01 9.6 0.71 0.48 to 1.05
LAC (n=69) 32.8 1.34 0.79 to 2.28 25.4 3.05 1.69 to 5.50
North America (n=163) 38.7 1.89 1.38 to 2.69 6.1 0.48 0.24 to 0.94
Oceania (n=40) 7.5 0.21 0.06 to 0.68 27.5 3.29 1.59 to 6.78
International (n=40) 10.0 0.21 0.06 to 0.68 10.0 0.89 0.31 to 2.56
*Regions based on United Nations Statistics Division classifications.
†United Nations region compared with the rest of the world.
LAC, Latin America and Caribbean.
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classification of their own actions and those conducted by the 
expert raters. Whereas ICAP/IARD classified most (75%) of 
the actions under the areas of leadership, drinking-driving 
countermeasures and reducing negative consequences, the 
raters found that almost one-third were too vague to classify 
and another 38% did not fit any of the WHO categories. As 
an industry-funded SAPRO, ICAP/IARD had a clear conflict 
of interest that could have biased their interpretation of 
the actions, as had been demonstrated in prior analyses of 
their international activities.27 28 Of note, most of the actions 
had start dates before the WHO Global strategy was issued, 
raising questions about the screening process used and the 
aims of the database.
Estimates of the public health benefits and harms showed 
that the overwhelming majority (96.8%) of industry actions 
lacked scientific support of their effectiveness in reducing 
harmful drinking and a small percentage (11.0%) had the 
potential for doing harm. The Guidelines on Implementa-
tion of Articles 5 and 13 of the WHO Framework Conven-
tion on Tobacco Control propose a ban on all contributions 
from tobacco companies to any other entity for ‘socially 
responsible’ causes as ‘the aim, effect, or likely effect…is 
to promote…(the) product or use, either directly or indi-
rectly’.29 Our analysis suggests that a similar ban would be 
appropriate for the alcohol industry. This caveat was reiter-
ated by then WHO Director General Margaret Chan in her 
statement that alcohol companies should have ‘no role in 
the formulation of alcohol policies, which must be protected 
from distortion by commercial or vested interests’.30
One strength of this study is its use of a global database 
of industry activities that is likely to be comprehensive and 
representative of the alcohol industry’s CSR activities. Our 
analysis indicates that those activities contribute minimally 
to the public health efforts of the WHO. This research also 
had some methodological limitations. Because of resource 
limitations, we evaluated only a sample from the IARD data-
base. Different conclusions may have resulted with a larger 
sample. In addition, we were not able to estimate the costs to 
the industry of the actions conducted to determine whether 
they represented significant charitable contributions or 
were merely activities that in some cases would have been 
conducted anyway (eg, staff training at breweries or actions 
Figure 1 Percent of industry actions classified by International Alliance for Responsible Drinking and by health professionals 
according to WHO Global strategy target areas.
Table 5 Activity type by level of effectiveness (n=1046)
Activity type (example) N
Evidence of effectiveness
None/Unknown Limited–moderate
Availability (MLPA, different availability by strength) 7 0.0 0.7
Environment (RBS training) 49 4.0 0.7
Drink-driving (designated driver campaigns, safe rides) 49 4.6 0.1
Brief intervention and treatment 5 0.0 0.5
Marketing (self-regulation codes) 67 6.2 0.2
Education and persuasion 75 6.1 1.1
‘Other’ (newsletters, industry-sponsored conferences) 794 75.9 0.0
Total 1046 96.8% 3.2%
MLPA, minimum legal purchase age; RBS, responsible beverage service.
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which are already required by law). Although raters were all 
trained to an acceptable level of reliability, we cannot rule 
out differential bias in the raters recruited from different 
regions.
COnClusIOn
This analysis provides a window into the CSR activities 
considered by the alcohol industry to have relevance to their 
response to the WHO Global strategy. The magnitude and 
global scope of these initiatives speaks to the ability of the 
alcohol industry to mobilise its diverse commercial compo-
nents in pursuit of a common cause, much like the tobacco 
industry did before them. Far from confirming industry 
claims that they can ‘do well’ by ‘doing good,’ the findings 
of the present study suggest that the public health benefits 
of their CSR activities are likely to be minimal, whereas the 
public relations benefits can be substantial.
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